Elevation Oncology, Inc. (ELEV)
NASDAQ: ELEV · IEX Real-Time Price · USD
7.89 0.08 (1.02%)
Oct 25, 2021 4:00 PM EDT - Market closed
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
| Year | 2020 | 2019 |
|---|---|---|
| Selling, General & Admin | 1.8 | 0.54 |
| Research & Development | 15.48 | 5.34 |
| Operating Expenses | 17.28 | 5.88 |
| Operating Income | -17.28 | -5.88 |
| Other Expense / Income | -0.01 | 0 |
| Pretax Income | -17.27 | -5.88 |
| Net Income | -17.27 | -5.88 |
| Net Income Common | -17.27 | -5.88 |
| Shares Outstanding (Basic) | 1 | 1 |
| Shares Outstanding (Diluted) | 1 | 1 |
| Shares Change | 6.43% | - |
| EPS (Basic) | -21.80 | -7.91 |
| EPS (Diluted) | -21.80 | -7.91 |
| Free Cash Flow Per Share | -15.62 | -7.33 |
| EBITDA | -17.25 | -5.88 |
| EBIT | -17.27 | -5.88 |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).